MR mammography firm Caprius has settled a shareholder class-action suit filed in January 1998 that accused the Wilmington, MA, company of overstating revenues (SCAN 1/14/98). Caprius made a cash payment of $150,000, of which $100,000 was
MR mammography firm Caprius has settled a shareholder class-action suit filed in January 1998 that accused the Wilmington, MA, company of overstating revenues (SCAN 1/14/98). Caprius made a cash payment of $150,000, of which $100,000 was contributed by the company's insurance carrier. Caprius also issued 325,000 shares of stock to the plaintiffs and agreed to make an additional payment of $75,000 if it sells all or part of its business in the next 12 months.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
2 Commerce Drive
Cranbury, NJ 08512